Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 5
2021 1
2023 3
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Advances in the treatment of metastatic prostate cancer.
Gebrael G, Fortuna GG, Sayegh N, Swami U, Agarwal N. Gebrael G, et al. Among authors: fortuna gg. Trends Cancer. 2023 Oct;9(10):840-854. doi: 10.1016/j.trecan.2023.06.009. Epub 2023 Jul 11. Trends Cancer. 2023. PMID: 37442702 Review.
Sequence not salvage.
Sborov DW, Fortuna GG, Hayden PJ. Sborov DW, et al. Among authors: fortuna gg. Br J Haematol. 2024 May;204(5):1590-1592. doi: 10.1111/bjh.19439. Epub 2024 Apr 2. Br J Haematol. 2024. PMID: 38563345
Predictors of response to neoadjuvant therapy in urothelial cancer.
Tripathi N, Fortuna GG, Gebrael G, Dal E, Mathew Thomas V, Gupta S, Swami U. Tripathi N, et al. Among authors: fortuna gg. Crit Rev Oncol Hematol. 2024 Feb;194:104236. doi: 10.1016/j.critrevonc.2023.104236. Epub 2023 Dec 19. Crit Rev Oncol Hematol. 2024. PMID: 38128631 Review.
Diagnosis and Treatment of Metastatic Disease to the Pancreas.
Cortez N, Berzosa M, Mahfouz M, Dvir K, Galarza Fortuna GM, Ben-David K. Cortez N, et al. Among authors: galarza fortuna gm. J Laparoendosc Adv Surg Tech A. 2020 Sep;30(9):1008-1012. doi: 10.1089/lap.2020.0219. Epub 2020 Jul 1. J Laparoendosc Adv Surg Tech A. 2020. PMID: 32614661
Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor.
Gebrael G, Jo Y, Mathew Thomas V, Li H, Sayegh N, Tripathi N, Srivastava A, Nordblad B, Dal E, Narang A, Brundage J, Campbell P, Galarza Fortuna G, Hage Chehade C, Maughan BL, Agarwal N, Swami U. Gebrael G, et al. Among authors: galarza fortuna g. Cancer. 2024 Apr 2. doi: 10.1002/cncr.35302. Online ahead of print. Cancer. 2024. PMID: 38564301
17 results